ABOS vs XPO · $73.3M cap vs P/E 69, rev $2.35B
Acumen Pharmaceuticals Inc (ABOS) versus XPO Logistics Inc (XPO) — a side-by-side from cached financials, not a winner call.
Acumen Pharmaceuticals Inc (ABOS) is a biotechnology company listed on US.
XPO Logistics Inc (XPO) is a trucking company listed on NYSE.
ABOS does not have a complete income-statement cache yet.
Latest reported XPO revenue for 2026-06-30 was $2.35B. Net income was $162.0M. Revenue was up 12.4% from 2026-03-31 to 2026-06-30. XPO currently screens at market cap $23.69B and trailing P/E 69.3.
ABOS currently screens at market cap $73.3M. XPO currently screens at market cap $23.69B and trailing P/E 69.3.
Not investment advice. Open the ABOS and XPO stock pages for the full models.
Not investment advice.